Navigation Links
Hospira Expands Board of Directors With Election of Dennis M. Fenton
Date:7/31/2012

LAKE FOREST, Ill., July 31, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that Dennis M. Fenton, Ph.D., has been elected to the company's board of directors. Dr. Fenton, a recognized manufacturing and biologics expert, has more than 30 years of healthcare industry experience. The addition of Dr. Fenton expands Hospira's board to 11 directors, 10 of whom are independent. 

"We are excited to welcome Dennis to Hospira's board of directors," said John C. Staley, chairman of the board. "His impressive track record of results-oriented leadership and pioneering contributions to biological manufacturing and operations quality make him an excellent fit."

F. Michael Ball, chief executive officer, added, "Dennis brings unparalleled experience in the pharmaceutical and biotechnology space, with differentiated expertise that spans manufacturing and quality overall, and biologics in particular. His appointment supports Hospira's commitment to establish manufacturing as a competitive advantage."

Dr. Fenton, 60, spent more than two decades at Amgen, where he served as one of the company's longest-tenured employees and its executive vice president of Operations until his retirement in 2008. Prior to Amgen, Dr. Fenton served as a senior research scientist at Pfizer.

Dr. Fenton is a member of the Society for Industrial Microbiology, held previous memberships in the American Chemical Society, the American Society for Microbiology and the Parenteral Drug Association, and was a director of the Biotechnology Industry Organization (BIO) and National Health Foundation. He currently serves on the boards of Dendreon Corporation, Napo Pharmaceuticals, Genelux Corporation, Xenoport and Kythera Biopharmaceuticals; and is a trustee of the Keck Graduate Institute and Rutgers University. A native of New York, Dr. Fenton holds a Bachelor of Science degree in biology from Manhattan College and a doctorate in microbiology from Rutgers University.

About Hospira
Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 15,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
2. Hospira Reports First-Quarter 2012 Results
3. Hospira to Present at Upcoming Investor Conferences
4. I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
5. Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
6. Hospira to Host Conference Call for Second-quarter 2012 Results
7. As Smartphone Usage Expands, Survey Says Nurses and Nursing Students Want Mobile Access to Credible Drug Data
8. BioSurplus Expands, Debuts New 8000 Square Foot Warehouse and Service Facility
9. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
10. Clinical Interest in BioElectronics Products Expands to the Wound Care Market
11. S1 Biopharma Expands Focus to Include Male Sexual Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2016)... - DCGI grants limited approval to market ... - Stempeucel® becomes 5th off-the-shelf Stem cell product to ... - Buerger,s Disease (also known as Thromboangiitis Obliterans) is a ... Globally - Prevalence of Buerger,s Disease is estimated to ... 10,000 persons in the European Community & USA ...
(Date:5/27/2016)... , May 27, 2016 According ... of hypertension is driving ambulatory blood pressure monitoring system ... elasticity and their ability to respond to different pressure ... condition can lead to various cardiovascular disorders such as ... disease. These diseases are growing in prevalence each year. ...
(Date:5/26/2016)... , May 26, 2016 According to ... Waste Management Market - U.S. Industry Analysis, Size, Share, Growth, ... market in the U.S. was valued at US$ 5.89 Bn ... of 3.4% from 2015 to 2023 to reach US$ 7.99 ... of current and emerging needle free drug delivery devices and ...
Breaking Medicine Technology:
(Date:5/28/2016)... , ... May 28, 2016 , ... In a part of the city where’s it’s ... new farm-to-table Kelowna restaurants is hoping to attract diners with a taste for ... Suites officially opened the doors to Cornerstone Grill, an urban casual restaurant focusing on ...
(Date:5/27/2016)... ... 27, 2016 , ... W.S. Badger Co. Inc ., the maker of ... recognized as one of the best small businesses for new dads by Fatherly, the ... small businesses providing progressive benefits to new parents on the organization’s 2016 Best ...
(Date:5/27/2016)... ... May 27, 2016 , ... An educational campaign aimed at ... stories, courtesy of awareness-driven celebrities and thought leaders. It also provides insight to ... industry leaders such as Bioness. , As patients feel increasingly concerned about ...
(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... Aimed ... inspiring human interest stories, which come courtesy of leaders in the nursing and health ... industry, from leading advocates and associations—namely Abilene Christian University. , As the nursing ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... There are ... Hot Dog and Sausage Council (NHDSC) suggests that Americans prefer their dogs straight off ... 63 percent say grilling is their favorite way to cook a hot dog, far ...
Breaking Medicine News(10 mins):